Cargando...
Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer
Ovarian cancer mortality is the highest among gynecologic malignancies. Hence, the major challenges are early diagnosis and efficient targeted therapy. Herein, we devised model theranostic nanoparticles (NPs) for combined diagnostics and delivery of chemotherapeutics, targeted to ovarian cancer cell...
Gardado en:
| Publicado en: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6572588/ https://ncbi.nlm.nih.gov/pubmed/31060303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11050216 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|